The FDA received reports of two deaths involving counterfeit retatrutide. Novo Nordisk also plans to discontinue Saxenda in early 2027.
The Latest
Bootleg Retatrutide Deaths? PMOS And Dementia; Weight-Loss Drug To Be Discontinued
CVS To Pay $315M To Settle Justice Department Case Over Opioid Prescriptions
CVS and subsidiaries will pay $315 million and add safeguards to resolve a Justice Department lawsuit alleging unlawful opioid dispensing.
Dementia Cases Rising; Tylenol’s Effect On Brain Organoids; Early-Onset Alzheimer’s
A meta-analysis estimates 11.4 million new dementia cases worldwide in 2023, with annual cases projected to reach 24.7 million by 2050.
Can Lowering Cholesterol Prevent Or Treat Alzheimer’s?
A Danish study links statin use with lower dementia risk, while an experimental drug changed an Alzheimer’s blood biomarker. Neither proves prevention or treatment.
15 Best Therapy Light Boxes for Depression in 2027
Compare 15 therapy light boxes for depression by brightness, controls, portability, design, and everyday fit, then choose the right style for your routine.
Friends’ Unrealistic Requests
Advice columnist R. Eric Thomas responds to a retired reader overwhelmed by friends’ requests for rides, errands and home repairs.
15 Best Therapy Books for Children in 2027
Compare 15 therapy books for children by age, format, and focus, from emotion stories and calming tools to structured workbooks for adult-guided use.
When You’re Doing Everything Right But Still Feel Lonely
A Tiny Buddha essay describes the gap between managing life independently and finding lasting connection, including a welcoming Christmas in Asheville.
Mystery Surrounds Young Worker’s Death At Russia Lab Studying Severe Diseases
The WHO says the cause of a young worker’s death at a Russian disease laboratory remains unknown after Russian officials reported more than 5,500 tests.
Buck Institute And Georgetown Lead Effort Mapping Harmful Protein Changes Before Disease Begins
An ARPA-H-backed four-year consortium will study how disordered proteins shift toward disease, focusing first on Alzheimer’s and Ewing sarcoma.
